OpenAI has acquired Orchestra Bio, a biotech startup. | The Verge
OpenAI describes Orchestra Bio as “a platform that helps biopharma teams coordinate the complex process of drug development.” The company will bring Orchestra’s team and tech “together with Rosalind, our AI models and tools for life sciences research.”
[Link: OpenAI acquires Orchestra Bio | https://openai.com/index/openai-to-acquire-orchestra-bio/ | OpenAI]